COVID-19: EU to contract with another vaccine producer

Portfolio
A few days after the European Commission contracted with BioNTech and Pfizer, it is to authorise on Tuesday a new contract to secure another COVID-19 vaccine for Europeans, EC President Ursula von der Leyen announced on Monday. This contract is to allow the EU executive to buy up to 405 million doses of a vaccine produced by the German company CureVac.
vakcina oltás járvány

Von der Leyen reminded that earlier this year, the Commission had provided funding to CureVac, together with the European Investment Bank, in a bid to support the development of this vaccine.

And now, progress is tangible. If the vaccine has proven safe and effective against COVID-19, every Member State will receive the vaccine at the same time, on a pro-rata basis, and under the same conditions.

This is the fifth contract with a pharmaceutical company for the EU's COVID-19 vaccine portfolio, and

the Commission is working on a sixth one, with Moderna.

"We have already concluded exploratory talks with Moderna. We hope to finalise the contract soon," added von der Leyen .

US biotech firm Moderna has announced impressive results, an efficacy of 94.5%, for its mRNA vaccine on Monday, a week after interim results for a Pfizer/BioNTech vaccine showed 90% effectivenes. The company said it "remains on track to manufacture 500 million to 1 billion doses globally in 2021.

Moderna said it had improved the shelf life and stability, meaning its vaccine can be stored for six months at -20C for shipping and long-term storage, and at standard refrigeration temperatures of 2C to 8C for 30 days.

She said that at this stage it is unclear which vaccines will end up being safe and effective, and that the European Medicines Agency EMA will authorise them "only after a robust assessment."

"This is why we need to have a broad portfolio of vaccines based on very different technologies. In parallel, we are working with COVAX to provide access to vaccines for low- and middle-income countries. Thus, we want to ensure that all have access rapidly to safe and effective vaccines," she added.

 

More in Economy

magyar nemzeti bank mnb jegybank
August 26, 2025 14:28

Hungary central bank keeps base rate on hold at 6.5%

For the 11th consecutive time

DSZZS20250731007 (1)
August 26, 2025 09:24

Price margin freeze to remain in place until the end of November - Gergely Gulyás

A number of important economic issues were discussed at the Government Press Briefing

GettyImages budapest parlament 517730688-duna-épület-híd-turizmus-város-világörökség-viz
August 25, 2025 12:17

Viktor Orbán's chief advisor reveals new details about upcoming action plan

Home Start isn't only aimed at young people, it turns out

forint apró 10 forint 20 forint 5 forint
August 25, 2025 08:59

Something is brewing on the forint market – the only question is what it will be

Will it suffer further setbacks or regain strength? This week will see

áruház-élelmiszer-fogyasztás-kiskereskedelem
August 22, 2025 13:10

Major retail chains react to margin cap extension

PM Orbán announced the extension of the margin cap in a closed Facebook group

LATEST NEWS
Charting is displayed using TradingView's technology, a platform, where you can build advanced charts, spot upcoming trends in the stock screener, and find inspiration in multiple trading ideas

Detailed search